Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 14.41% is 357% above its 5-year average of -5.61%, near the high end of its 5-year range (-28.95%–14.41%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.07% above its 12-month average of 13.34%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 14.41%.
RETURN ON INVESTED CAPITAL (ROIC)
14.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
13.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
1.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-5.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.07%
CURRENT VS 3Y AVG
+800.82%
CURRENT VS 5Y AVG
+356.98%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+140.42%
vs the sector median at left
Krystal Biotech, Inc.
Market Cap
$9.63B
Return on Invested Capital (ROIC)
14.41%
TTM Avg
13.34%
3Y Avg
1.60%
5Y Avg
-5.61%
Market Cap
$9.63B
Return on Invested Capital (ROIC)
-40.65%
TTM Avg
-24.67%
3Y Avg
-27.62%
5Y Avg
-28.57%
Market Cap
$9.66B
Return on Invested Capital (ROIC)
6.53%
TTM Avg
6.69%
3Y Avg
7.80%
5Y Avg
8.31%
Market Cap
$9.87B
Return on Invested Capital (ROIC)
1.85%
TTM Avg
0.17%
3Y Avg
2.33%
5Y Avg
3.34%
Market Cap
$9.93B
Return on Invested Capital (ROIC)
1.54%
TTM Avg
2.53%
3Y Avg
2.92%
5Y Avg
2.77%
Market Cap
$9.33B
Return on Invested Capital (ROIC)
16.04%
TTM Avg
12.65%
3Y Avg
9.01%
5Y Avg
7.29%
Market Cap
$10.03B
Return on Invested Capital (ROIC)
7.29%
TTM Avg
7.04%
3Y Avg
6.95%
5Y Avg
7.54%
Market Cap
$9.21B
Return on Invested Capital (ROIC)
2.56%
TTM Avg
2.83%
3Y Avg
6.99%
5Y Avg
7.71%
Market Cap
$10.13B
Return on Invested Capital (ROIC)
8.90%
TTM Avg
10.00%
3Y Avg
10.19%
5Y Avg
11.72%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | $9.63B | 14.41% | 13.34% | 1.60% | -5.61% |
| Vaxcyte, Inc. (PCVX)vs › | $9.63B | -40.65% | -24.67% | -27.62% | -28.57% |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 6.53% | 6.69% | 7.80% | 8.31% |
| Repligen Corporation (RGEN)vs › | $9.87B | 1.85% | 0.17% | 2.33% | 3.34% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 1.54% | 2.53% | 2.92% | 2.77% |
| Insulet Corp. (PODD)vs › | $9.33B | 16.04% | 12.65% | 9.01% | 7.29% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 7.29% | 7.04% | 6.95% | 7.54% |
| Bruker Corporation (BRKR)vs › | $9.21B | 2.56% | 2.83% | 6.99% | 7.71% |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 8.90% | 10.00% | 10.19% | 11.72% |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | -45.63% | -80.95% | -90.71% | -98.29% |
ROIC
14.4%
ROE
17.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 14.41% |
| 2026-03-31 | 13.87% |
| 2025-12-31 | 13.10% |
| 2025-09-30 | 13.77% |
| 2025-06-30 | 11.52% |
| 2025-03-31 | 9.80% |
| 2024-12-31 | 6.44% |
| 2024-09-30 | 2.81% |
| 2024-06-30 | -2.42% |
| 2024-03-31 | -8.11% |
| 2023-12-31 | -11.84% |
| 2023-09-30 | -19.36% |
| 2023-06-30 | -23.19% |
| 2023-03-31 | -28.95% |
| 2022-12-31 | -22.70% |
| 2022-09-30 | -19.57% |
| 2022-06-30 | -16.14% |
| 2022-03-31 | -14.22% |
| 2021-12-31 | -11.37% |
| 2021-09-30 | -13.68% |
| 2021-06-30 | -11.95% |
| 2021-03-31 | -9.54% |
| 2020-12-31 | -11.17% |
| 2020-09-30 | -9.44% |
| 2020-06-30 | -7.81% |
| 2020-03-31 | -11.60% |
| 2019-12-31 | -10.73% |
| 2019-09-30 | -9.57% |
| 2019-06-30 | -8.83% |
| 2019-03-31 | -12.75% |
| 2018-12-31 | -10.50% |
| 2018-09-30 | -17.50% |
| 2018-06-30 | -18.37% |
| 2018-03-31 | -13.89% |
| 2017-12-31 | -9.64% |
| 2017-09-30 | -7.76% |
| 2017-06-30 | -62.54% |
